Does DOSTARLIMAB-GXLY Cause Off label use? 51 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Off label use have been filed in association with DOSTARLIMAB-GXLY. This represents 10.1% of all adverse event reports for DOSTARLIMAB-GXLY.
51
Reports of Off label use with DOSTARLIMAB-GXLY
10.1%
of all DOSTARLIMAB-GXLY reports
4
Deaths
6
Hospitalizations
How Dangerous Is Off label use From DOSTARLIMAB-GXLY?
Of the 51 reports, 4 (7.8%) resulted in death, 6 (11.8%) required hospitalization, and 2 (3.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOSTARLIMAB-GXLY. However, 51 reports have been filed with the FAERS database.
What Other Side Effects Does DOSTARLIMAB-GXLY Cause?
Rash (42)
Death (28)
Malignant neoplasm progression (28)
Fatigue (22)
Neuropathy peripheral (20)
Pyrexia (20)
Product use in unapproved indication (19)
Thrombocytopenia (16)
Hypothyroidism (14)
Erythema (13)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which DOSTARLIMAB-GXLY Alternatives Have Lower Off label use Risk?
DOSTARLIMAB-GXLY vs DOTATATE GALLIUM GA-68
DOSTARLIMAB-GXLY vs DOTHIEPIN
DOSTARLIMAB-GXLY vs DOXAZOSIN
DOSTARLIMAB-GXLY vs DOXAZOSIN\DOXAZOSIN
DOSTARLIMAB-GXLY vs DOXEPIN